Business · 23/05/2019Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 24 Abbreviated New Drug Applications from Bedford Laboratories and Others
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 24 abbreviated new drug applications (ANDAs) from multiple applicants, including Bedford Laboratories, after receiving written notifications that the corresponding drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →